Tag: Blood Disorders
Antibodies Decrease With Time After COVID-19 Symptom Onset
For all donors of convalescent plasma, drop seen in anti-RBD antibody levels from first to last donation
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk
No Proof Convalescent Plasma Effective Against COVID-19
NIH panel says data are insufficient to recommend either for or against the use of convalescent plasma
WHO: Plasma Therapy for COVID-19 Still Experimental
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
Convalescent Plasma Efficacious for Severe COVID-19
Significant reduction seen in mortality, specifically among patients transfused with plasma within 72 hours
Evidence Poor for Accuracy of Serological Tests for COVID-19
Evidence for diagnostic accuracy of serological tests characterized by high risks of bias, heterogeneity
FBI Warns of Scammers Selling Fake COVID-19 Antibody Tests
Consumers can protect themselves by checking FDA website for a list of approved antibody tests, testing companies
Antibody Tests ID COVID-19 Two to Three Weeks After Symptoms
After onset of symptoms, sensitivity is low in first week, increases in second week, peaks in third week
